好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults
Neuro-rehabilitation
P3 - Poster Session 3 (11:45 AM-12:45 PM)
4-007
To examine the association between prior traumatic brain injury (TBI) and depressive symptoms among community-dwelling older adults. 
Mood symptoms and behavioral dysregulation are recognized short-term sequelae of TBI. Research regarding the burden of depressive symptoms among older, community-based persons with TBI remains limited.

The Atherosclerosis Risk in Communities (ARIC) Study is an ongoing prospective cohort study comprised of 15,792 community-dwelling adults in the U.S. who were initially recruited in 1987–1989. History of TBI was defined using self-report and hospital-based diagnostic codes and was analyzed as a time-varying exposure. Episodic depressive symptoms and prescribed antidepressants were assessed at Visits 5 (2011–2013), Visit 6 (2016–2017), and Visit 7 (2018–2019). Depressive symptoms were measured using the Center for Epidemiologic Studies Depression (CESD) scale 11-item version, with a cut-point of ≥9 used to define clinically significant depressive symptoms. We used generalized estimating equations (GEE) with an autoregressive working correlation structure and a binomial distribution with a log link to estimate risk ratios (RR) for the association of head-injury with time-varying depressive symptoms and prescribed anti-depressants, adjusting for age, sex, race/center, educational attainment, household income, and prior military service.  

Of the 6,607 participants included the median age was 75 years (25th-75th percentiles=72–80). More than half were female (59.0%) and 23.7% were Black. There were 2,113 participants (32.0%) with history of TBI, most of which were classified as mild. In adjusted GEE models, history of TBI was associated with increased risk of episodic depressive symptoms (RR=1.59, 95%CI: 1.37–1.85) and prescribed antidepressants (RR=1.32, 95%CI: 1.20–1.45) over Visits 5–7. These results persisted in analysis of subgroups defined by age, sex, and race.

We observed a persistant and robust association of TBI with depressive symptoms and prescribed antidepressants in this cohort of older, community-dwelling adults.  
Authors/Disclosures
Holly Elser, MD, PhD (Hospital of the University of Pennsylvania)
PRESENTER
Dr. Elser has nothing to disclose.
Rogan Magee, MD, PhD (Penn Medicine) Dr. Magee has nothing to disclose.
Sabrina Abbruzzese Ms. Abbruzzese has nothing to disclose.
Danielle Sandsmark, MD The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Rebecca F. Gottesman, MD, PhD (Johns Hopkins University) The institution of Dr. Gottesman has received research support from NIH.
Tom Mosley, PhD Dr. Mosley has nothing to disclose.
David A. Wolk, MD, FAAN (University of Pennsylvania) Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Andrea L. Schneider, MD, PhD (University of Pennsylvania) Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.